Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer

dc.contributor.author	Shetty, Praveenkumar K.
dc.contributor.author	Patil, Vidya S.
dc.contributor.author	Rajashekar, Mohan
dc.contributor.author	D’Souza, Leonard Clinton
dc.contributor.author	Bargale, Anil
dc.contributor.author	Patil, Basavaraj R.
dc.contributor.author	Dinesh, U. S.
dc.contributor.author	Haridas, Vikram
dc.contributor.author	Kulkarni, Shreerang P.
dc.date.accessioned	2018-03-02T10:06:34Z
dc.date.available	2018-03-02T10:06:34Z
dc.date.issued	2017
dc.identifier.citation	Annals of Clinical Biochemistry. 2017; 54(4): 463–471.	en_US
dc.identifier.issn	0004-5632, 1758-1001
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1011
dc.language.iso	en	en_US
dc.publisher	Sage Publisher	en_US
dc.subject	Tumour markers	en_US
dc.subject	TNBC
dc.subject	AnxA2 receptor ligands
dc.subject	Immunoassay
dc.subject	HER2
dc.subject	Breast neoplasms-diagnosis
dc.title	Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer	en_US
dc.type	Article	en_US